Full Press Release Details
New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI (inotersen) for the Treatment of Hereditary ATTR Amyloidosis.
IONS
New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI (inotersen) for the Treatment of Hereditary ATTR Amyloidosis
Key Takeaway: New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI (inotersen) for the Treatment of Hereditary ATTR Amyloidosis